JAMA Editorials Provide Taste of LDT Regulation Debate to Come at Public Hearing | GenomeWeb

NEW YORK (GenomeWeb) – In a pair of editorials published this week in the Journal of the American Medical Association, industry experts have laid out arguments for and against US Food and Drug Administration oversight of the lab industry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.